Trial Profile
ACE/ACE2 ratio in diabetic patients treated with antihypertensive drugs
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 03 Dec 2005 New trial record.